Step Pharma
0 followers
‌
Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populations.
Industries
Headquarters
Employees
Links
Org chart
Andrew Parker
Collapse
Duc Tran
Chief Development Officer
Nicolas Marsault
Chief Financial Officer
Philip Beer
Chief Scientific Officer
Thien Duc Tran
Chief Development Officer (CDO)
Brian Schwartz
Chief Medical Officer
Roger Franklin
Partner, Hadean Ventures
Sylvain Latour
Scientific Founder
Maureen Higgins
VP, Head of Clinical Operations
Hélène Asnagli
Senior Director, Head of Pharmacology
